Reporting Event: FDASTF - FDA Standard Safety Tables and Figures
List of Contents: List of Planned Analyses (LOPA)
1. Table 2. Baseline Demographic and Clinical Characteristics, Safety Population, Trial CDISCPILOT01
  Output: O_T2 - Table 2. Baseline Demographic and Clinical Characteristics, Safety Population, Trial CDISCPILOT01
    Documentation:
      > Standard Safety Tables and Figures: Integrated Guide (https://downloads.regulations.gov/FDA-2022-N-1961-0046/attachment_1.pdf)
        - Pages 12-13 [Table 2]
    Output File(s):
      > RTF Format: t2-demog (RTF) (./t2-demog.rtf)
      > PDF Format: t2-demog (PDF) (./t2-demog.pdf)
    Displays:
      1. D_T2 - Table 2
        Display Title: Table 2. Baseline Demographic and Clinical Characteristics, Safety Population, Trial CDISCPILOT01
        Sections:
          > Title:
            1. Table 2. Baseline Demographic and Clinical Characteristics, Safety Population, Trial CDISCPILOT01
          > Footer:
            1. Source dataset: adsl, Generated on: DDMONYYYY:HH:MM
          > Rowlabel Header:
            1. Characteristic
          > Abbreviation:
            1. N, number of patients in treatment arm
            2. n, number of patients with given characteristic
            3. SD, standard deviation
  1.1. Summary of Subjects by Treatment
    Analysis: A_SAF_SUM_USUBJID_TRT - Summary of Subjects by Treatment
      Documentation:
        Reason: SPECIFIED IN SAP
        Purpose: PRIMARY OUTCOME MEASURE
        See:
          > Statistical Analysis Plan (./sap.pdf)
            - Page 9 [6. ANALYSIS POPULATIONS]
      Population: AS_SAF - Safety Population
        Selection Criteria: ADSL.SAFFL EQ 'Y'
      Groupings:
        1. AG_TRT - Treatment
          Grouping Variable: ADSL.TRT01A
          Groups [Results per group: Y]:
            1. AG_TRT_1 - Placebo
               Selection Criteria: ADSL.TRT01A EQ 'Placebo'
            2. AG_TRT_2 - Xanomeline Low Dose
               Selection Criteria: ADSL.TRT01A EQ 'Xanomeline Low Dose'
            3. AG_TRT_3 - Xanomeline High Dose
               Selection Criteria: ADSL.TRT01A EQ 'Xanomeline High Dose'
      Analysis Variable: ADSL.USUBJID
      Method: M_GRP_CNT - Count by group for a categorical variable (Grouped count for categorical variable)
              Count across groups for a categorical variable, based on subject occurrence
        Operations:
          1. M_GRP_CNT_1_N - Count of subjects (n)
  1.2. Sex
    1.2.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_SEX - Summary of Subjects by Treatment and Sex
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: AS_SAF - Safety Population
          Selection Criteria: ADSL.SAFFL EQ 'Y'
        Groupings:
          1. AG_TRT - Treatment
            Grouping Variable: ADSL.TRT01A
            Groups [Results per group: Y]:
              1. AG_TRT_1 - Placebo
                 Selection Criteria: ADSL.TRT01A EQ 'Placebo'
              2. AG_TRT_2 - Xanomeline Low Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline Low Dose'
              3. AG_TRT_3 - Xanomeline High Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline High Dose'
          2. AG_SEX - Gender
            Grouping Variable: ADSL.SEX
            Groups [Results per group: Y]:
              1. AG_SEX_1 - Male
                 Selection Criteria: ADSL.SEX EQ 'M'
              2. AG_SEX_2 - Female
                 Selection Criteria: ADSL.SEX EQ 'F'
        Analysis Variable: ADSL.USUBJID
        Method: M_GRP_SUM_CATEG - Summary by group of a categorical variable (Grouped summary of categorical variable)
                Descriptive summary statistics across groups for a categorical variable, based on subject occurrence
          Operations:
            1. M_GRP_SUM_CATEG_1_N - Count of subjects (n)
            2. M_GRP_SUM_CATEG_2_PCT - Percent of subjects (%)
                - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
                - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
  1.3. Age
    1.3.1. Summary of Age by Treatment
      Analysis: A_SAF_SUM_AGE_TRT - Summary of Age by Treatment
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: AS_SAF - Safety Population
          Selection Criteria: ADSL.SAFFL EQ 'Y'
        Groupings:
          1. AG_TRT - Treatment
            Grouping Variable: ADSL.TRT01A
            Groups [Results per group: Y]:
              1. AG_TRT_1 - Placebo
                 Selection Criteria: ADSL.TRT01A EQ 'Placebo'
              2. AG_TRT_2 - Xanomeline Low Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline Low Dose'
              3. AG_TRT_3 - Xanomeline High Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline High Dose'
        Analysis Variable: ADSL.AGE
        Method: M_GRP_SUM_CONTIN - Summary by group of a continuous variable (Grouped summary of continuous variable)
                Descriptive summary statistics across groups for a continuous variable
          Operations:
            1. M_GRP_SUM_CONTIN_1_MEAN - Mean (Mean)
            2. M_GRP_SUM_CONTIN_2_SD - Standard deviation (SD)
            3. M_GRP_SUM_CONTIN_3_MEDIAN - Median (Median)
            4. M_GRP_SUM_CONTIN_4_MIN - Minimum (min)
            5. M_GRP_SUM_CONTIN_5_MAX - Maximum (max)
  1.4. Age groups
    1.4.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_AGEGRP - Summary of Subjects by Treatment and Age Group
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: AS_SAF - Safety Population
          Selection Criteria: ADSL.SAFFL EQ 'Y'
        Groupings:
          1. AG_TRT - Treatment
            Grouping Variable: ADSL.TRT01A
            Groups [Results per group: Y]:
              1. AG_TRT_1 - Placebo
                 Selection Criteria: ADSL.TRT01A EQ 'Placebo'
              2. AG_TRT_2 - Xanomeline Low Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline Low Dose'
              3. AG_TRT_3 - Xanomeline High Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline High Dose'
          2. AG_AGEGR2 - Age groups
            Grouping Variable: ADSL.AGEGR2
            Groups [Results per group: Y]:
              1. AG_AGEGR2_1 - < 65
                 Selection Criteria: ADSL.AGEGR2 EQ '<65'
              2. AG_AGEGR2_2 - ≥ 65
                 Selection Criteria: ADSL.AGEGR2 EQ '65+'
          3. AG_AGEGR3 - Age sub-groups
            Grouping Variable: ADSL.AGEGR3
            Groups [Results per group: Y]:
              1. AG_AGEGR3_1 - ≥17 to <65
                 Selection Criteria: ADSL.AGEGR3 EQ '17-<65'
              2. AG_AGEGR3_2 - ≥ 65 to <75
                 Selection Criteria: ADSL.AGEGR3 EQ '65-<75'
              3. AG_AGEGR3_3 - ≥ 75
                 Selection Criteria: ADSL.AGEGR3 EQ '75+'
        Analysis Variable: ADSL.USUBJID
        Method: M_GRP_SUM_CATEG - Summary by group of a categorical variable (Grouped summary of categorical variable)
                Descriptive summary statistics across groups for a categorical variable, based on subject occurrence
          Operations:
            1. M_GRP_SUM_CATEG_1_N - Count of subjects (n)
            2. M_GRP_SUM_CATEG_2_PCT - Percent of subjects (%)
                - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
                - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
  1.5. Race
    1.5.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_RACE - Summary of Subjects by Treatment and Race
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: AS_SAF - Safety Population
          Selection Criteria: ADSL.SAFFL EQ 'Y'
        Groupings:
          1. AG_TRT - Treatment
            Grouping Variable: ADSL.TRT01A
            Groups [Results per group: Y]:
              1. AG_TRT_1 - Placebo
                 Selection Criteria: ADSL.TRT01A EQ 'Placebo'
              2. AG_TRT_2 - Xanomeline Low Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline Low Dose'
              3. AG_TRT_3 - Xanomeline High Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline High Dose'
          2. AG_RACE - Race
            Grouping Variable: ADSL.RACE
            Groups [Results per group: Y]:
              1. AG_RACE_1 - American Indian or Alaska Native
                 Selection Criteria: ADSL.RACE EQ 'AMERICAN INDIAN OR ALASKA NATIVE'
              2. AG_RACE_2 - Black or African American
                 Selection Criteria: ADSL.RACE EQ 'BLACK OR AFRICAN AMERICAN'
              3. AG_RACE_3 - Native Hawaiian or Other Pacific Islander
                 Selection Criteria: ADSL.RACE EQ 'NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER'
              4. AG_RACE_4 - White
                 Selection Criteria: ADSL.RACE EQ 'WHITE'
              5. AG_RACE_5 - Other
                 Selection Criteria: ADSL.RACE NOTIN ('AMERICAN INDIAN OR ALASKA NATIVE', 'BLACK OR AFRICAN AMERICAN', 'NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER', 'WHITE')
        Analysis Variable: ADSL.USUBJID
        Method: M_GRP_SUM_CATEG - Summary by group of a categorical variable (Grouped summary of categorical variable)
                Descriptive summary statistics across groups for a categorical variable, based on subject occurrence
          Operations:
            1. M_GRP_SUM_CATEG_1_N - Count of subjects (n)
            2. M_GRP_SUM_CATEG_2_PCT - Percent of subjects (%)
                - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
                - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
  1.6. Ethnicity
    1.6.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_ETHNIC - Summary of Subjects by Treatment and Ethnicity
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: AS_SAF - Safety Population
          Selection Criteria: ADSL.SAFFL EQ 'Y'
        Groupings:
          1. AG_TRT - Treatment
            Grouping Variable: ADSL.TRT01A
            Groups [Results per group: Y]:
              1. AG_TRT_1 - Placebo
                 Selection Criteria: ADSL.TRT01A EQ 'Placebo'
              2. AG_TRT_2 - Xanomeline Low Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline Low Dose'
              3. AG_TRT_3 - Xanomeline High Dose
                 Selection Criteria: ADSL.TRT01A EQ 'Xanomeline High Dose'
          2. AG_ETHNIC - Ethnicity
            Grouping Variable: ADSL.ETHNIC
            Groups [Results per group: Y]:
              1. AG_ETHNIC_1 - Hispanic or Latino
                 Selection Criteria: ADSL.ETHNIC EQ 'HISPANIC OR LATINO'
              2. AG_ETHNIC_2 - Not Hispanic or Latino
                 Selection Criteria: ADSL.ETHNIC EQ 'NOT HISPANIC OR LATINO'
        Analysis Variable: ADSL.USUBJID
        Method: M_GRP_SUM_CATEG - Summary by group of a categorical variable (Grouped summary of categorical variable)
                Descriptive summary statistics across groups for a categorical variable, based on subject occurrence
          Operations:
            1. M_GRP_SUM_CATEG_1_N - Count of subjects (n)
            2. M_GRP_SUM_CATEG_2_PCT - Percent of subjects (%)
                - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
                - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
